Topics

High-grade gliomas | Treatment | Targeted therapy

Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy

□ OVERVIEW

□ AUCELICICLIB

□ ANLOTINIB

□ APATINIB

□ AVAPRITINIB

□ BEVACIZUMAB

□ BIOMARKER-MATCHED

□ CAMRELIZUMAB

□ DABRAFENIB

□ FEXAGRATINIB

□ HYPOXIA-TARG RADIOLIG THER

□ IPILIMUMAB

□ LAROTRECTINIB

□ LENVATINIB

□ NILOTINIB

□ NIVOLUMAB

□ NIMOTUZUMAB

□ OLAPARIB

□ PEMBROLIZUMAB

□ PARP INHIBITORS

□ SAMOTOLISIB

□ SM-1

□ SORAFENIB

□ SYHA1813

□ TG02

□ TARG RADIONUCLIDE THERAPY

□ TERAMEPROCOL

□ TRAMETINIB

□ TISLELIZUMAB

□ VEMURAFENIB

□ VORASIDENIB